rs398607

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000153.4(GALC):ā€‹c.1685T>Cā€‹(p.Ile562Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.465 in 1,576,428 control chromosomes in the GnomAD database, including 174,846 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign,other (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.49 ( 19109 hom., cov: 32)
Exomes š‘“: 0.46 ( 155737 hom. )

Consequence

GALC
NM_000153.4 missense

Scores

3
9
6

Clinical Significance

Benign; other criteria provided, multiple submitters, no conflicts B:11O:5

Conservation

PhyloP100: 9.29
Variant links:
Genes affected
GALC (HGNC:4115): (galactosylceramidase) This gene encodes a lysosomal protein which hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.962683E-4).
BP6
Variant 14-87941544-A-G is Benign according to our data. Variant chr14-87941544-A-G is described in ClinVar as [Benign, other]. Clinvar id is 92497.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-87941544-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.597 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GALCNM_000153.4 linkuse as main transcriptc.1685T>C p.Ile562Thr missense_variant 15/17 ENST00000261304.7 NP_000144.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GALCENST00000261304.7 linkuse as main transcriptc.1685T>C p.Ile562Thr missense_variant 15/171 NM_000153.4 ENSP00000261304 P1P54803-1

Frequencies

GnomAD3 genomes
AF:
0.492
AC:
74706
AN:
151734
Hom.:
19079
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.603
Gnomad AMI
AF:
0.500
Gnomad AMR
AF:
0.397
Gnomad ASJ
AF:
0.491
Gnomad EAS
AF:
0.186
Gnomad SAS
AF:
0.424
Gnomad FIN
AF:
0.476
Gnomad MID
AF:
0.459
Gnomad NFE
AF:
0.478
Gnomad OTH
AF:
0.486
GnomAD3 exomes
AF:
0.433
AC:
107634
AN:
248542
Hom.:
24679
AF XY:
0.435
AC XY:
58669
AN XY:
134844
show subpopulations
Gnomad AFR exome
AF:
0.610
Gnomad AMR exome
AF:
0.316
Gnomad ASJ exome
AF:
0.485
Gnomad EAS exome
AF:
0.175
Gnomad SAS exome
AF:
0.420
Gnomad FIN exome
AF:
0.479
Gnomad NFE exome
AF:
0.475
Gnomad OTH exome
AF:
0.445
GnomAD4 exome
AF:
0.462
AC:
658766
AN:
1424576
Hom.:
155737
Cov.:
30
AF XY:
0.462
AC XY:
328556
AN XY:
711174
show subpopulations
Gnomad4 AFR exome
AF:
0.610
Gnomad4 AMR exome
AF:
0.326
Gnomad4 ASJ exome
AF:
0.483
Gnomad4 EAS exome
AF:
0.195
Gnomad4 SAS exome
AF:
0.418
Gnomad4 FIN exome
AF:
0.470
Gnomad4 NFE exome
AF:
0.477
Gnomad4 OTH exome
AF:
0.454
GnomAD4 genome
AF:
0.493
AC:
74789
AN:
151852
Hom.:
19109
Cov.:
32
AF XY:
0.488
AC XY:
36174
AN XY:
74186
show subpopulations
Gnomad4 AFR
AF:
0.603
Gnomad4 AMR
AF:
0.396
Gnomad4 ASJ
AF:
0.491
Gnomad4 EAS
AF:
0.187
Gnomad4 SAS
AF:
0.425
Gnomad4 FIN
AF:
0.476
Gnomad4 NFE
AF:
0.478
Gnomad4 OTH
AF:
0.491
Alfa
AF:
0.470
Hom.:
41782
Bravo
AF:
0.489
TwinsUK
AF:
0.497
AC:
1843
ALSPAC
AF:
0.485
AC:
1869
ESP6500AA
AF:
0.614
AC:
2248
ESP6500EA
AF:
0.481
AC:
3934
ExAC
AF:
0.440
AC:
53173
Asia WGS
AF:
0.398
AC:
1382
AN:
3478
EpiCase
AF:
0.465
EpiControl
AF:
0.463

ClinVar

Significance: Benign; other
Submissions summary: Benign:11Other:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Galactosylceramide beta-galactosidase deficiency Benign:5Other:3
not provided, no classification providedliterature onlyGeneReviews-- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -
not provided, no classification providedphenotyping onlyGenomeConnect - Invitae Patient Insights Network-Variant interpreted as Benign and reported on 11-13-2019 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. -
other, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 08, 2019- pseudodeficiency allele
Benign, criteria provided, single submitterresearchBroad Center for Mendelian Genomics, Broad Institute of MIT and Harvard-The p.Ile562Thr variant in GALC has been identified in 1 Japanese individual with Krabbe disease (PMID: 24252386). This variant is classified as benign for autosomal recessive Krabbe disease because it has been identified in >60% of African chromosomes by ExAC (http://gnomad.broadinstitute.org/). -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
not specified Benign:4
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Oct 27, 2015- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
not provided Benign:2Other:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 04, 2018This variant is associated with the following publications: (PMID: 32661301, 27126738, 26865610, 27535533, 24078576, 26795590, 24252386) -
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-Variant identified in multiple GenomeConnect participants. Variant classified as Benign (pseudodeficiency allele) and reported, most recently, on 06-18-2021 by Lab or GTR ID 500031. Variant also classified as Benign and reported on 09-16-2019 by GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
not provided, no classification providedphenotyping onlyGenomeConnect - Brain Gene Registry-Variant reported in multiple GenomeConnect participants by mulitple clinical testing laboratories. Variant classified as other/Benign by all laboratories and reported most recently on 05-11-2022 by Variantxy and on 01-25-2022 by Invitae. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.61
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Uncertain
0.020
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.85
D;.;.;.
Eigen
Uncertain
0.19
Eigen_PC
Benign
0.20
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.95
D;D;D;D
MetaRNN
Benign
0.00050
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.0
M;.;.;.
MutationTaster
Benign
0.99
P;P;P;P
PrimateAI
Benign
0.39
T
PROVEAN
Uncertain
-3.0
D;D;D;D
REVEL
Uncertain
0.51
Sift
Uncertain
0.017
D;D;T;D
Sift4G
Uncertain
0.0050
D;D;D;D
Polyphen
0.46
P;P;P;.
Vest4
0.56
MPC
0.20
ClinPred
0.039
T
GERP RS
5.7
Varity_R
0.20
gMVP
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs398607; hg19: chr14-88407888; COSMIC: COSV54324831; API